Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre …

B Ogutu, A Yeka, S Kusemererwa… - The Lancet Infectious …, 2023 - thelancet.com
Background Emergence of drug resistance demands novel antimalarial drugs with new
mechanisms of action. We aimed to identify effective and well tolerated doses of …
被引用次数：5 相关文章

Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre …

B Ogutu, A Yeka, S Kusemererwa, R Thompson… - 2023 - cabidigitallibrary.org
Background: Emergence of drug resistance demands novel antimalarial drugs with new
mechanisms of action. We aimed to identify effective and well tolerated doses of …

Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre …

B Ogutu, A Yeka, S Kusemererwa… - The Lancet. Infectious …, 2023 - europepmc.org
Background Emergence of drug resistance demands novel antimalarial drugs with new
mechanisms of action. We aimed to identify effective and well tolerated doses of …

Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre …

B Ogutu, A Yeka, S Kusemererwa… - The Lancet …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Emergence of drug resistance demands novel antimalarial drugs with new
mechanisms of action. We aimed to identify effective and well tolerated doses of …

Ganaplacide (KAF156) plus lumefantrine solid dispersion formulation combination for uncomplicated Plasmodium falciparum malaria: an open-label, multicentre …

B Ogutu, A Yeka, S Kusemererwa, R Thompson… - The Lancet Infectious …, 2023 - Elsevier
Background Emergence of drug resistance demands novel antimalarial drugs with new
mechanisms of action. We aimed to identify effective and well tolerated doses of …